Literature DB >> 20433339

Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria.

Rachel J Wenke1, Petrea Cornwell, Deborah G Theodoros.   

Abstract

The present study aimed to evaluate the effects of the Lee Silverman Voice Treatment (LSVT(R)) on acoustic and perceptual measures of articulation in non-progressive dysarthria in comparison to traditional dysarthria therapy. The study involved 26 individuals with non-progressive dysarthria who were randomly allocated to receive either LSVT(R) or traditional dysarthria therapy (TRAD), both of which were administered for 16 hourly sessions over 4 weeks. Participants' speech samples were collected over a total of six testing sessions during three assessment phases: (1) prior to treatment, (2) immediately post-treatment, and (3) 6 months post-treatment (FU). Speech samples were analysed perceptually to determine articulatory precision and intelligibility as well as acoustically using vowel space (and vowel formant measures) and first moment differences. Results revealed short and long-term significant increases in vowel space area following LSVT(R). Significantly increased intelligibility was also found at FU in the LSVT(R) group. No significant differences between groups for any variables were found. The study reveals that LSVT(R) may be a suitable treatment option for improving vowel articulation and subsequent intelligibility in some individuals with non-progressive dysarthria.

Entities:  

Mesh:

Year:  2010        PMID: 20433339     DOI: 10.3109/17549500903568468

Source DB:  PubMed          Journal:  Int J Speech Lang Pathol        ISSN: 1754-9507            Impact factor:   2.484


  13 in total

1.  Optimizing Vowel Formant Measurements in Four Acoustic Analysis Systems for Diverse Speaker Groups.

Authors:  Ekaterini Derdemezis; Houri K Vorperian; Ray D Kent; Marios Fourakis; Emily L Reinicke; Daniel M Bolt
Journal:  Am J Speech Lang Pathol       Date:  2016-08-01       Impact factor: 2.408

2.  Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.

Authors:  Kris Tjaden; Joan E Sussman; Gregory E Wilding
Journal:  J Speech Lang Hear Res       Date:  2014-06-01       Impact factor: 2.297

3.  Vowel acoustics in Parkinson's disease and multiple sclerosis: comparison of clear, loud, and slow speaking conditions.

Authors:  Kris Tjaden; Jennifer Lam; Greg Wilding
Journal:  J Speech Lang Hear Res       Date:  2013-07-09       Impact factor: 2.297

4.  Formant transitions in varied utterance positions.

Authors:  Christina Kuo
Journal:  Folia Phoniatr Logop       Date:  2013-12-19       Impact factor: 0.849

Review 5.  Static measurements of vowel formant frequencies and bandwidths: A review.

Authors:  Raymond D Kent; Houri K Vorperian
Journal:  J Commun Disord       Date:  2018-06-01       Impact factor: 2.288

Review 6.  Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury.

Authors:  Claire Mitchell; Audrey Bowen; Sarah Tyson; Zoe Butterfint; Paul Conroy
Journal:  Cochrane Database Syst Rev       Date:  2017-01-25

7.  Consonant Acoustics in Parkinson's Disease and Multiple Sclerosis: Comparison of Clear and Loud Speaking Conditions.

Authors:  Kris Tjaden; Vincent Martel-Sauvageau
Journal:  Am J Speech Lang Pathol       Date:  2017-06-22       Impact factor: 2.408

8.  ReaDySpeech for people with dysarthria after stroke: protocol for a feasibility randomised controlled trial.

Authors:  Claire Mitchell; Audrey Bowen; Sarah Tyson; Paul Conroy
Journal:  Pilot Feasibility Stud       Date:  2017-07-20

9.  Feasibility and Acceptability of Lee Silverman Voice Treatment in Progressive Ataxias.

Authors:  Anja Lowit; Aisling Egan; Marios Hadjivassiliou
Journal:  Cerebellum       Date:  2020-10       Impact factor: 3.847

10.  Effect of boost articulation therapy (BArT) on intelligibility in adults with dysarthria.

Authors:  Viviana Mendoza Ramos; Charlotte Paulyn; Leen Van den Steen; Maria E Hernandez-Diaz Huici; Marc De Bodt; Gwen Van Nuffelen
Journal:  Int J Lang Commun Disord       Date:  2021-01-23       Impact factor: 3.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.